Skip to main content
Clinical Trials/CTRI/2017/10/010125
CTRI/2017/10/010125
Completed
未知

Multi-centric Study for Screening and detection of oral potentially malignant disorders (OPMD) non-invasively by fluorescence and diffuse reflectance imaging with OralScan camera, and development of an algorithm for tissue discrimination

Sascan Meditech Pvt Ltd0 sites336 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Men and women above 20 years with OPMD lesions such as leukoplakia, erythroplakia, OSMF, dysplasia and moderate to well differentiated squamous cell carcinoma.
Sponsor
Sascan Meditech Pvt Ltd
Enrollment
336
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
December 30, 2019
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Sascan Meditech Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients presenting with oral potentially malignant disorder (OPMD) lesions such as leukoplakia, erythroplakia, oral sub mucous fibrosis (OSMF), dysplasia and moderate to well differentiate squamous cell cancer.
  • 2\.Healthy Volunteers without tobacco/pan/gutka/arrecanut/cigarette or beedi smoking/alcohol habits and any visible symptoms of other diseases or tissue inflammation in the oral cavity

Exclusion Criteria

  • 1\.Previous treatments for cancer.
  • 2\.Patients with systemic conditions that contraindicates biopsy.
  • 3\.Recent application of any medication orally for at least four weeks.
  • 4\.Patients not willing to participate

Outcomes

Primary Outcomes

Not specified

Similar Trials